Compound Summary
Dobutamine hydrochloride
Compound Information
Dobutamine hydrochloride
Compound Name: | Dobutamine hydrochloride |
Compound CID: | 65324 |
Synonyms: | Dobutamine hydrochloride 49745-95-1 Dobutamine Hcl Dobutrex Inotrex More... |
Iupac Name: | 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochloride |
InChI: | InChI=1S/C18H23NO3.ClH/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15;/h4-9,12-13,19-22H,2-3,10-11H2,1H3;1H |
InChIKey: | BQKADKWNRWCIJL-UHFFFAOYSA-N |
Canonical Smiles: | CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O.Cl |
Isomeric Smiles: | CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O.Cl |
Molecular Weight: | 337.8 |
Molecular Formula: | C18H24ClNO3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Dobutamine hydrochloride
Molecular Weight: | 337.8 |
Molecular Formula: | C18H24ClNO3 |
Hydrogen Bond Donor Count: | 5 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 7 |
Heavy Atom Count: | 23 |
Complexity: | 305 |
Synonyms
Dobutamine hydrochloride
| Dobutamine hydrochloride | Dobutamine hydrochloride |
|---|---|
Dobutamine hydrochloride |
49745-95-1 |
Dobutamine Hcl |
Dobutrex |
Inotrex |
Dobutamine (hydrochloride) |
DL-Dobutamine hydrochloride |
52663-81-7 |
1,2-Benzenediol, 4-2-3-(4-hydroxyphenyl)-1-methylpropylaminoethyl-, hydrochloride (1:1) |
49745-95-1 (HCl) |
MFCD00153795 |
NSC-299583 |
4-2-4-(4-hydroxyphenyl)butan-2-ylaminoethylbenzene-1,2-diol hydrochloride |
4-2-4-(4-hydroxyphenyl)butan-2-ylaminoethylbenzene-1,2-diol;hydrochloride |
(+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol hydrochloride |
CHEBI:4671 |
1,2-Benzenediol, 4-2-3-(4-hydroxyphenyl)-1-methylpropylaminoethyl-, hydrochloride |
4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol hydrochloride |
SMR000058435 |
Dobutamina clorhidrato Spanish |
SR-01000075265 |
LY 81929 |
EINECS 256-464-1 |
NSC 299583 |
LY 46236 |
Posiject |
1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride |
4-(2-(4-(4-hydroxyphenyl)butan-2-ylamino)ethyl)benzene-1,2-diol hydrochloride |
4-(2-{4-(4-hydroxyphenyl)butan-2-ylamino}ethyl)benzene-1,2-diol hydrochloride |
S-1000 |
Dobutrex (TN) |
Prestwick_741 |
Dobutamine hydrochloride in dextrose 5% |
Dobutamine hydrochloride USAN:USP:BAN:JAN |
rac Dobutamine Hydrochloride |
SCHEMBL41609 |
1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride, (+-)- |
MLS000860012 |
MLS001332503 |
MLS001332504 |
MLS002222253 |
REGID_for_CID_65324 |
CHEMBL1200418 |
DTXSID30964383 |
Dobutamine hydrochloride, >=98% |
Dobutamine hydrochloride in dextrose 5% in plastic container |
HMS1569G05 |
BCP13026 |
Tox21_500365 |
NSC299583 |
Dobutamine hydrochloride (JP17/USP) |
AKOS015907731 |
CCG-220352 |
CCG-221669 |
KS-1050 |
LP00365 |
(+/-)-3,4-Dihydroxy-N-3-(4-hydroxyphenyl)-1-methylpropyl-beta-phenethylamine hydrochloride |
4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatecholhydrochloride |
NCGC00093799-01 |
NCGC00093799-02 |
NCGC00261050-01 |
AC-11653 |
HY-15746 |
LY-46236 |
Q711 |
AB0017762 |
DB-051684 |
D4335 |
EU-0100365 |
FT-0625557 |
FT-0681170 |
D 0676 |
D00632 |
368D042 |
A827836 |
SR-01000075265-1 |
SR-01000075265-3 |
SR-01000075265-6 |
W-106009 |
Q27106435 |
Dobutamine hydrochloride, British Pharmacopoeia (BP) Reference Standard |
Dobutamine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
(.+-.)-4-2-3-(p-Hydroxyphenyl)-1-methylpropylaminoethylpyrocatechol hydrochloride |
1, 4-2-3-(4-hydroxyphenyl)-1-methylpropylaminoethyl-, hydrochloride, (.+-.)- |
3,4-Dihydroxy-N-3-(4-hydroxyphenyl)-1-methylpropyl-beta-phenethylamine Hydrochloride |
4-2-3-(4-Hydroxyphenyl)-1-methylpropylaminoethyl-1,2-benzenediol hydrochloride |
Dobutamine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
( inverted question mark)-4-2-3-(4-Hydroxyphenyl)-1-methylpropylaminoethyl-1,2-benzenediol hydrochloride |
Experimental Data
Dobutamine hydrochloride
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 8.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Dobutamine hydrochloride
Statistics Data
Dobutamine hydrochloride
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 8.000000000000000 | 1 | 1 |
Statistics Data Visualization
Dobutamine hydrochloride
